ClinicalTrials.gg
RecruitingNCT06213272Updated Aug 13, 2026

Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits

An interventional study of Phono-Motor Therapy and Aerobic Exercise Training (AET) in Stroke, Aphasia and Reading Disorder, sponsored by Kessler Foundation. Recruiting at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by Kessler Foundation · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The goal of the proposed project is to test the effectiveness of a novel hybrid approach to treatment of reading disorders after stroke, in which exercise training will be used in combination with a targeted reading treatment. This approach is expected to increase cerebral circulation and help to rebuild and strengthen the damaged phonological neural networks. Through this combinatory approach, the study aims to enhance the reading and language improvements seen with existing treatments.

Read the detailed description

Close to 2.5 million Americans are currently living with post-stroke aphasia, a debilitating communication disorder affecting multiple language modalities. Most stroke survivors with aphasia have acquired reading deficits, which persist chronically and severely limit life participation and autonomy. There is an urgent need for effective treatments grounded in stroke neurobiology which yield robust functional improvements. This project is a randomized controlled trial, which will recruit 70 individuals with chronic left-hemisphere stroke. Participants will complete 40 sessions of targeted reading treatment combined with either 20 minutes of moderate aerobic exercise or light stretching. Participants will undergo 3 Magnetic Resonance Imaging (MRI) scans, administered before the intervention, after the initial exercise session, and after the full course of treatment. They will also complete behavioral testing before and after the intervention. The outcome of this study has the potential to radically change how reading treatments are applied, increasing their effectiveness, and ultimately improving the lives of 2.5 million Americans living with stroke-related aphasia. In addition, it is likely that the results will contribute to the understanding of stroke recovery mechanisms thereby fundamentally advancing the field of neurorehabilitation.

02

Conditions studied

  • Stroke
  • Aphasia
  • Reading Disorder

Keywords

  • exercise
  • stroke
  • aphasia
  • reading therapy
  • phono-motor therapy
  • aerobic exercise treatment
  • MRI
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 70 is above the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Kessler Foundation is the lead sponsor of 175 studies on the registry; 61 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • fluent and literate in English prior to stroke
  • 1st ever stroke
  • more than 3 months post-stroke
  • post-stroke reading deficits, defined as reading aloud accuracy \<83% for single words or \<65% for readable nonwords
  • living within a 50-mile radius from Kessler Foundation.

Exclusion criteria

Exclusion Criteria:

  • to MRI
  • prior neurological disease
  • developmental learning or reading disability (i.e., developmental dyslexia)
  • contraindication to exercise
  • concurrent speech and language therapy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Aerobic Exercise Treatment (AET) combined with Phono-Motor Therapy (PMT)

    Patients will receive 40, once-daily 2-hour intervention sessions administered 4-5 times per week by trained research assistants. Sessions will begin with a 5-min warm-up, followed by 20 min of aerobic exercise (cycling, 60% heart rate range), and a 5-min cool-down. Participants will rate their perceived effort every 5 minutes and complete a log at the end of each session to characterize their experience. When HR returns to near resting levels (i.e., 5-min after cool-down), participants will undertake the PMT for the remaining 90 min.

    Behavioral: Phono-Motor Therapy · Behavioral: Aerobic Exercise Training (AET)

  • Active comparator
    Stretching and PMT

    Patients will receive 40, once-daily 2-hour intervention sessions administered 4-5 times per week by trained research assistants. Sessions will begin with a 5-min warm-up, followed by 20 min of stretching and a 5-min cool-down. Stretching activities will target the head/neck, shoulder, elbow/forearm, hand/wrist, trunk/hip, ankle/foot. Participants will complete a log at the end of each session to characterize their experience, and within 5 min of completing the last stretching activity, participants will undertake PMT for the remaining 90 min of a given session.

    Behavioral: Phono-Motor Therapy · Behavioral: Stretching

Interventions

  • BehavioralPhono-Motor Therapy

    The goal of PMT is to build orthographic and phonological awareness and phonological sequence knowledge. During PMT, participants will complete a series of tasks manipulating minimal sound units (consonants (C) \& vowels (V)), combining these units into syllables (CVC, CVCC, CCVC) and syllable sequences (real words and readable nonwords). PMT will aim to engage 5 modalities: visual, acoustic, tactile kinesthetic, motor, and orthographic. Multisyllabic stimuli used during treatment will consist of 40 real words and 68 readable nonword letter strings.

  • BehavioralAerobic Exercise Training (AET)

    Stationary ergometer cycling at 60% heart rate range for 20 minutes, plus 5 minutes of warm up and cool down.

  • BehavioralStretching

    Light stretching activities targeting the head/neck, shoulder, elbow/forearm, hand/wrist, trunk/hip, ankle/foot.

06

What researchers measure

Primary outcomes

  1. Reading Aloud

    Participants will read aloud 120 words and 80 nonwords, some of which will be selected for PMT based on individual accuracy (treated items). A subset of these will not be treated and will be used to assess generalization.

    Time frame: Baseline and within 2 weeks of treatment completion (~10 weeks from study onset)

  2. 2 Alternative Forced Choice Computer Tasks

    Touch-screen computer tests of semantics, phonology, \& orthography (composite score). Participants choose one of two examples on the screen that matches a target in meaning (semantics), rhymes with the target (phonology), or chose a letter string that more closely resembles a word.

    Time frame: Baseline and within 2 weeks of treatment completion (~10 weeks from study onset)

  3. Reading Comprehension Battery for Aphasia - 2nd edition (RCBA-2)

    Letter, word, sentence, paragraph, and text-level reading comprehension test for aphasia.

    Time frame: Baseline and within 2 weeks of treatment completion (~10 weeks from study onset)

  4. Cerebral Blood Flow (CBF)

    CBF will be measured using an Arterial Spin Labeling MRI sequence

    Time frame: Baseline, after a single session of acute exercise, and within 2 weeks of treatment completion (~10 weeks from study onset)

  5. Resting State Functional Connectivity (rsFC)

    RsFC will be measured using fMRI acquired with rapid simultaneous multi-slice echo-planar imaging (EPI) (TR=1.5s, TE=30ms, 44 slices, gap = .5mm, 2mm isotropic voxels, N volumes=400, eyes open). To standardize the rest condition across participants, we will instruct participants to look at a centrally presented fixation dot for the duration of the scan.

    Time frame: Baseline, after a single session of acute exercise, and within 2 weeks of treatment completion (~10 weeks from study onset)

  6. Task-induced fMRI activation

    Data will be collected using fMRI sequence above. Participants will perform a reading aloud task where words or nonwords are presented on the screen one at a time. The order of reading blocks (words/nonwords) will be randomized (9 blocks of each\*2 runs). Each 32 s reading block will have 8 words (blocked by condition, e.g., high imagery, frequency, and consistency) or nonwords, presented for 1 s and followed by \~3s response period. The onset of each word or nonword stimulus will be randomly jittered by 100-400ms to provide the ability to model errors. Voice responses will be collected via an MR microphone (FOMRI III+, Optoacoustics) and used to score reading accuracy. Reading aloud accuracy will be evaluated by 2 independent raters, and disagreements will be resolved by discussion. The reading aloud blocks will be alternated with baseline fixation blocks (12s) and rest blocks (8s) for a total duration of 52s for each block cycle (7.8 min run)

    Time frame: Baseline and within 2 weeks of treatment completion (~10 weeks from study onset)

Secondary outcomes

  1. Western Aphasia Battery Revised

    A comprehensive assessment of language impairments in aphasia

    Time frame: Baseline and within 2 weeks of treatment completion (~10 weeks from study onset)

  2. Philadelphia Naming Test (Short)

    A 30-tem picture naming test designed to identify word finding difficulties. It is presented on a computer using line drawn images of animate and inanimate objects and is audio recorded.

    Time frame: Baseline and within 2 weeks of treatment completion (~10 weeks from study onset)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The scientific data and metadata generated by this project will be securely archived in several repositories. Our study design will be hosted on ClinicalTrials.gov, the code will be stored on GitHub, and the neuroimaging data alongside behavioral datasets will be deposited on OpenNeuro.org. Each repository will contain links to the others, ensuring seamless accessibility and discoverability of all associated data and metadata across the platforms.

Supporting information: Study protocol, Clinical study report, Analytic code

Time frame: Data sharing will occur no later than the time of an associated publication of primary study outcomes or 1 year from the end of the performance period, whichever comes first. Data stored in repositories such as OpenNeuro.org, GitHub, and ClinicalTrials.gov are typically retained long term, often without a predetermined deletion date. Therefore, barring any unforeseen changes to these platforms' policies, the data from this project will be available for an indefinite period of time, allowing scientific community to access and utilize the available information.

Access criteria: Access to the scientific data will require users to create an account with the respective repository (GitHub or OpenNeuro.org). After this step, they will be able to freely access and use the data, following the repository's terms of use. Study design data, which will be hosted on ClinicalTrials.gov, will be available to users without registration.

Data sharing details ↗ · openneuro.org

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06213272
Lead sponsor
Kessler Foundation
Responsible party
Olga Boukrina (Research Scientist, Kessler Foundation) — Principal investigator
First posted
Jan 19, 2024
Start date
Apr 18, 2024
Primary completion
Mar 1, 2029 (estimated)
Completion
Mar 1, 2029 (estimated)
Last update
Aug 13, 2026

Study contacts

Olga Boukrina, PhD
Contact
oboukrina@kesslerfoundation.org
19733243587
Matthew R Weiner
Contact
mweiner@kesslerfoundation.org
973-323-3745
Olga Boukrina
principal investigator · Kessler Foundation

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion